Myelomatous effusion with poor response to chemotherapy

33Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

While pleural effusion in multiple myeloma is relatively infrequent, myelomatous pleural effusion is extremely rare. We experienced a 61-year-old woman with IgD-λ multiple myeloma and pleural effusion. The diagnosis was made originally by pleural biopsy, pleural fluid cytology and immunoelectrophrosis of pleural fluid. Transient improvement of the pleural effusion was observed after administration of combination chemotherapy of vincristine, melphalan, cyclophosphamide, pednisone (VMCP) / vincristine, cyclophosphamide, adriamycin, prednisone (VCAP). Two months later, myelomatous pleural effusion recurred and no response to salvage therapy was observed. We reviewed the clinical feature of this case and literature concerning myelomatous pleural effusion. Copyright © The Korean Academy of Medical Sciences.

Cite

CITATION STYLE

APA

Kim, Y. M., Lee, K. K., Oh, H. S., Park, S. K., Won, J. H., Hong, D. S., … Lee, D. W. (2000). Myelomatous effusion with poor response to chemotherapy. Journal of Korean Medical Science, 15(2), 243–246. https://doi.org/10.3346/jkms.2000.15.2.243

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free